PCI Decision Letter
Decision letter for B.Pharm and D.Pharm. It lists permanent approval under Section 12(1) and an approved intake of 60 for each course for the stated course years.
Document: 2026–2027 onward course years
At Hindupat Institute of Pharmacy, academic excellence is
built upon a strong foundation of statutory approvals,
regulatory compliance, and institutional integrity. Every
programme offered by the institute is governed by the
standards prescribed by the competent regulatory authorities,
ensuring that students receive education of the highest
quality and national relevance.
Our approvals and affiliations reflect our unwavering
commitment to maintaining academic standards, professional
ethics, transparency, and continuous quality enhancement.
The pharmacy programmes offered by the institute
are approved by the Pharmacy Council of India (PCI),
New Delhi, the statutory body constituted under the
Pharmacy Act, 1948.
This approval ensures that the institute adheres to
the prescribed academic framework, infrastructure
standards, laboratory facilities, faculty requirements,
and professional guidelines essential for quality
pharmaceutical education.
View the institute's uploaded approval and affiliation records for the relevant courses and academic sessions. Please check each document for its stated session, course, intake, and conditions before relying on it.
The institute is affiliated with Rajiv Gandhi
Proudyogiki Vishwavidyalaya (RGPV), Bhopal,
one of Madhya Pradesh's leading technological
universities.
The affiliation ensures that students pursue a
curriculum designed in accordance with contemporary
pharmaceutical education, supported by an examination
system and academic framework that meet university
and regulatory standards.
Open or download the documents supplied by the institute. The academic session shown below follows the wording inside each document.
Decision letter for B.Pharm and D.Pharm. It lists permanent approval under Section 12(1) and an approved intake of 60 for each course for the stated course years.
Document: 2026–2027 onward course yearsRGPV notification for B.Pharm (PCI), with an intake capacity of 60. The uploaded notification explicitly states academic session 2025–2026.
Ref. F-5/Acad./Affiliation/575/RGPV/2026/6020 · 13 Aug 2026Note: The RGPV notification supplied here states session 2025–2026; it should not be described as a 2026–2027 affiliation letter unless an updated notification is available.
Every approval and affiliation represents more than
regulatory recognition—it reflects our responsibility
towards students, parents, and society.
At Hindupat Institute of Pharmacy, we remain committed to:
The credibility of an institution is measured not only by its approvals but by its commitment to excellence. At Hindupat Institute of Pharmacy, every recognition reinforces our dedication to nurturing competent pharmacists who combine scientific knowledge, professional ethics, and humanitarian values to serve society with distinction.